Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 84,208 | 39,996 | 31,668 | 12,821 | 9,797 |
| Operating Income | -84,208 | -39,996 | -31,668 | -12,821 | -9,797 |
| Interest Expense | 0 | 20 | 25 | 16 | 0 |
| Other Income | 6,597 | 3,878 | 70 | 189 | 131 |
| Pre-tax Income | -77,611 | -36,138 | -31,623 | -12,648 | -9,666 |
| Income Tax | N/A | 6 | 9 | N/A | N/A |
| Net Income Continuous | -77,611 | -36,144 | -31,632 | -12,648 | -9,666 |
| Net Income | $-77,611 | $-36,144 | $-31,632 | $-12,648 | $-9,666 |
| EPS Basic Total Ops | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| EPS Basic Continuous Ops | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| EPS Diluted Total Ops | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| EPS Diluted Continuous Ops | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -1.18 | -1.19 | -0.65 | -1.01 |
| EBITDA(a) | $-84,208 | $-39,547 | $-31,269 | $-12,623 | $-9,767 |